VASCULAR INJURY TREATMENT MARKET ANALYSIS

Vascular Injury Treatment MarketSize and Trends

Global Vascular Injury Treatment Market Drivers

The global vascular injury treatment market is expected to witness significant growth over the forecast period due to increasing number of collaborations by hospital to provide therapeutic solution for heart related diseases. For instance, in 2019, Mayo Clinic Health System and OU Children's Hospital entered into a collaboration for rare heart disease research (Hypoplastic Left Heart Syndrome). In addition, they are collaborating with the number of hospitals globally for the treatment of rare heart disease. Moreover, Children's Hospital at OU Medicine collaborated with five other Hypoplastic Left Heart Syndrome (HLHS) Consortium members, including Mayo Clinic, Children's Hospital of Philadelphia, Children's Hospital of Los Angeles, Children's Minnesota, and the Children's Hospital Colorado.

Moreover, in 2018, Mayo Clinic Health System entered into collaboration with Eko to develop data-driven technology that will help physician to detect potential dangerous heart diseases. Also, Eko and Mayo Clinic has announced to develop and commercialize a machine based algorithm that will help to screen the patient for the presence of a low ejection fraction (a weak heart pump). Hence, increasing launches of new technology for detection of heart related disease is expected to propel growth of the global vascular injury treatment market over the forecast period. For instance, according to the WHO, 17.9 million people die each year from cardiovascular disease. Therefore, increasing prevalence of the cardiovascular disease is one of the factors that is expected to drive growth of the global vascular injury treatment market over the forecast period.